多重用药中的躯体化：隐匿于众目睽睽之下。
Somatization in Polypharmacy: Hiding in Plain Sight.
作者信息
Schuh Michael J, Garcia Susan
机构信息
Mayo Clinic Florida.
出版信息
Innov Pharm. 2024 May 31;15(2). doi: 10.24926/iip.v15i2.6168. eCollection 2024.
Abstract
Polypharmacy and somatic symptom disorder (SSD) are common conditions clinicians see every day in practice. Polypharmacy is easy to identify and causation seems to be straightforward. However, SSD may not be so obvious and may be an underlying cause of the polypharmacy that may be more difficult to identify. Identifying SSD as a potential psychiatric cause for polypharmacy and understanding that adding more medications will not adequately resolve the patient's symptoms is important to prevent polypharmacy from being exacerbated.
摘要
多重用药和躯体症状障碍（SSD）是临床医生在日常实践中常见的情况。多重用药很容易识别，其病因似乎一目了然。然而，SSD可能不那么明显，并且可能是多重用药的一个潜在原因，而这可能更难识别。将SSD识别为多重用药的潜在精神科病因，并认识到增加更多药物并不能充分缓解患者症状，对于防止多重用药情况恶化很重要。
相似文献
1
Somatization in Polypharmacy: Hiding in Plain Sight.
Innov Pharm. 2024 May 31;15(2). doi: 10.24926/iip.v15i2.6168. eCollection 2024.
2
Bilateral Anterior Capsulotomy for the Treatment of Refractory Somatic Symptom Disorder: A Case Report.
Front Integr Neurosci. 2022 Jan 18;15:721833. doi: 10.3389/fnint.2021.721833. eCollection 2021.
3
Comparison of death anxiety symptoms between generalized anxiety disorder and somatization disorder in geriatric patients attending a psychiatric outpatient clinic for the first time.
J Psychiatr Res. 2024 Aug;176:93-97. doi: 10.1016/j.jpsychires.2024.05.016. Epub 2024 Jun 1.
4
Assessing the New DSM-5 Diagnosis of Somatic Symptom Disorder.
Psychosom Med. 2016 Jan;78(1):2-4. doi: 10.1097/PSY.0000000000000287.
5
Physician Care Coordination and the Use of Psychotropic Polypharmacy in the Management of Pediatric Mental Disorders.
J Manag Care Spec Pharm. 2019 Jan;25(1):29-38. doi: 10.18553/jmcp.2019.25.1.029.
6
How symptoms of simple acute infections affect the SSS-8 and SSD-12 as screening instruments for somatic symptom disorder in the primary care setting.
Front Psychiatry. 2023 Apr 17;14:1114782. doi: 10.3389/fpsyt.2023.1114782. eCollection 2023.
7
Insomnia and related mental health conditions: Essential neurobiological underpinnings towards reduced polypharmacy utilization rates.
Sleep Med. 2024 Jan;113:198-214. doi: 10.1016/j.sleep.2023.11.033. Epub 2023 Nov 29.
8
[Treatment of somatic symptom disorder in childhood: evidence-based psychotherapy interventions].
Orv Hetil. 2020 Jun;161(25):1050-1058. doi: 10.1556/650.2020.31740.
9
Detecting DSM-5 somatic symptom disorder: criterion validity of the Patient Health Questionnaire-15 (PHQ-15) and the Somatic Symptom Scale-8 (SSS-8) in combination with the Somatic Symptom Disorder - B Criteria Scale (SSD-12).
Psychol Med. 2020 Jan;50(2):324-333. doi: 10.1017/S003329171900014X. Epub 2019 Feb 7.
10
Psychobehavioral B-Criteria of Somatic Symptom Disorder Are Associated with Somatic Symptom Reporting in a Large Sample of Psychosomatic Outpatients.
Complex Psychiatry. 2024 Feb 7;10(1-4):10-18. doi: 10.1159/000536668. eCollection 2024 Jan-Dec.
本文引用的文献
1
Prescribing Cascades with Recommendations to Prevent or Reverse Them: A Systematic Review.
Drugs Aging. 2023 Dec;40(12):1085-1100. doi: 10.1007/s40266-023-01072-y. Epub 2023 Oct 20.
2
Medication-overuse headache: clinical profile and management strategies.
Neurosciences (Riyadh). 2023 Jan;28(1):13-18. doi: 10.17712/nsj.2023.1.20220115.
3
Pharmacogenomics and Drug-Induced Phenoconversion Informed Medication Safety Review in the Management of Pain Control and Quality of Life: A Case Report.
J Pers Med. 2022 Jun 15;12(6):974. doi: 10.3390/jpm12060974.
4
Somatic symptom disorder: a scoping review on the empirical evidence of a new diagnosis.
Psychol Med. 2022 Mar;52(4):632-648. doi: 10.1017/S0033291721004177. Epub 2021 Nov 15.
5
An overview of prevalence, determinants and health outcomes of polypharmacy.
Ther Adv Drug Saf. 2020 Jun 12;11:2042098620933741. doi: 10.1177/2042098620933741. eCollection 2020.
6
Evidence-Based Applications of Combination Psychotherapy and Pharmacotherapy for Depression.
Focus (Am Psychiatr Publ). 2016 Apr;14(2):156-173. doi: 10.1176/appi.focus.20150042. Epub 2016 Apr 7.
7
Polypharmacy as a Clinical Pharmacist Specialist Practice.
Sr Care Pharm. 2020 Jan 1;35(1):34-37.
8
Comparing the diagnostic concepts of ICD-10 somatoform disorders and DSM-5 somatic symptom disorders in patients from a psychosomatic outpatient clinic.
J Psychosom Res. 2018 Oct;113:74-80. doi: 10.1016/j.jpsychores.2018.08.001. Epub 2018 Aug 2.
9
What is polypharmacy? A systematic review of definitions.
BMC Geriatr. 2017 Oct 10;17(1):230. doi: 10.1186/s12877-017-0621-2.
10
Neurobiology of fear and specific phobias.
Learn Mem. 2017 Aug 16;24(9):462-471. doi: 10.1101/lm.044115.116. Print 2017 Sep.
Zotero 插件